ArticlePharmacoEconomics2025

Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability.

Marcelien H E Callenbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.